Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2025-12-24 @ 6:37 PM
Study NCT ID:
NCT06752057
Status:
RECRUITING
Last Update Posted:
2024-12-30
First Post:
2024-12-20
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
Sponsor:
The First Affiliated Hospital of Nanchang University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ISL2024316
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None